IODINE - Stearns Packaging Corporation | Lab Express International
- Manufacturer
- Stearns Packaging Corporation | Lab Express International
- Effective date
- 2025-11-24
- Label type
- OTC ANIMAL DRUG LABEL
- Version
- 4
- Source
- full-release
- Hydrated at
- 2026-06-01 02:45:12
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
GENERAL PRECAUTIONS SECTION
IODOPHORS are considered relatively non-toxic, but should always
be used in accordance with label directions. Consult your veterinarian in case of teat irritation.
TEAT DIPPING IN COLD WEATHER:
When the temperature falls below 10 degrees F, or when wind chill is significant,
special precautions should be taken to avoid chapped and frozen teats.
1. Teats should be dry before turning cows out into cold weather.
2. When teats are dipped after milking, allow 30 seconds contact, and blot off any excess
teat dip with a single service towel.
3. Warm the teat dip to reduce drying time.
4. Provide windbreaks in outside areas for cows.
5. Monitor fresh cows with swollen udders and teats since they are more susceptible to
chapped and frozen teats.
DESCRIPTION SECTION
PRODUCT INFORMATION: This teat dip is an IODOPHOR (a combination of
iodine and complexing agents), and when properly used, is effective as an
aid in reducing the spread of mastitis causing organisms.
DOSAGE & ADMINISTRATION SECTION
DO NOT DILUTE.
USE AT FULL STRENGTH.
PROTECT FROM FREEZING
Important Use Instructions
For Pre-Milking
1. Wash each individual teat with a sanitizing udder wash.
NOTE: For best results, keep hair around teat based clipped.
2. Hand strip teats to initial let down.
3. Pre-dip entire teat with PRE-POST 1/2% on all four quarters. Repeat process on next 4 to
6 cows or until first cow prepped has at least 1 minute contact time.
4. Wipe each individual teat with a clean paper towel. Utilize a "pulling down" motion which
removes iodine solution, germs, and sediment from teat skin. Very important!
5. Place machine on cow and repeat wiping process on remaining cows that have
been predipped.
For Post Milking
DIRECTIONS FOR TEAT DIPPING. Dip entire teat with undiluted dip solution. Allow to air
dry and remain on teats for prolonged contact time. Clean, sanitize and thoroughly dry
each teat prior to next milking. Replace dip solution when visibly cloudy or dirty.
USER SAFETY WARNINGS SECTION
FIRST-AID:
EYES: If contact with eyes occurs, flush with plenty of cool water for 15
minutes. Consult a physician.
INTERNAL: May be harmful if swallowed. If ingested, drink large
amounts of water. DO NOT induce vomiting. Get medical attention
immediately.
24 HOUR EMERGENCY CONTACT
1-800-255-3924
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
DAIRYLAND BRAND
PRE-POST 1/2%
A SANITIZING PRE AND POST DIP
NPE-Free Aid in Reducing the Spread of
Organisms Which May Cause Mastitis
Active Ingredient...........................0.5% Available Iodine
Emollient System Contains............5% GlycerinMinimum pH...................................4.0
KEEP OUT OF THE REACH OF CHILDREN
See side panel for Precautionary StatementsSTEARNS PACKAGING CORPORATION
4200 Sycamore Ave. (53714), PO Box 3216, Madison, WI 53704
(800) 655-5008
www.stearnspkg.com
NET CONTENTS: 1 U.S. FL. GALLON (3.78 LITERS)
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 1012340 | Dairyland Brand PRE-POST 1/2 % , 0.5 % Teat Dip | PSN | 4 |
| 991290 | iodine 0.5 % Topical Solution | PSN | 4 |
| 1012340 | iodine 5 MG/ML Topical Solution [Dairyland Brand Controlled Iodine Teat Dip] | SBD | 4 |
| 991290 | iodine 5 MG/ML Topical Solution | SCD | 4 |
| 1012340 | Dairyland Brand Controlled Iodine Teat Dip 0.5 % Topical Solution | SY | 4 |
| 1012340 | Dairyland Brand Controlled Iodine Teat Dip 5 MG/ML Topical Solution | SY | 4 |
| 991290 | iodine 0.5 % Topical Solution | SY | 4 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 5f30b278-5791-4113-8781-878a9221ef8a | Product name | 2 | 20230125 |
| 2a70c781-a755-4d76-b20a-a958acfbdcdc | Product name | 2 | 20190619 |
| 304592ef-4a8a-4c22-8e8c-af73aa3d60e5 | Product name | 1 | 20180703 |
| ac0821a1-ce75-4ea7-880a-59eecaecdf22 | Product name | 1 | 20180703 |
| db5dc4f9-b907-46f6-8fb7-babcf04bbe5c | Product name | 1 | 20180619 |
| 41e9d6cf-3ed7-4c44-a57e-0685058d0896 | Product name | 1 | 20170824 |
| 5e652c92-68fd-426b-b0e7-5fc64e0b9f99 | Product name | 1 | 20170309 |
| ddc0c11a-bba8-408f-b3c7-c4828b4bcc8c | Product name | 1 | 20150421 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 60282-2106-1 | Dairyland Brand Pre-Post | 3.78 L in 1 BOTTLE, PLASTIC | LIQUID | 3.78 | 4 | |
| 60282-2106-2 | Dairyland Brand Pre-Post | 18.93 L in 1 PAIL | LIQUID | 18.93 | 4 | |
| 60282-2106-3 | Dairyland Brand Pre-Post | 56.78 L in 1 DRUM | LIQUID | 56.78 | 4 | |
| 60282-2106-4 | Dairyland Brand Pre-Post | 208.2 L in 1 DRUM | LIQUID | 208.2 | 4 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| IODINE | ACTIVE INGREDIENT | 9679TC07X4 | 1 | |
| IODINE | ACTIVE MOIETY | 9679TC07X4 | 1 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | 1 |
Products#
Every source-derived product name is available through these pages.
- Dairyland Brand Pre-Post
- IODINE
- GLYCERIN
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 60282-2106 | 60282-2106-1, 60282-2106-2, 60282-2106-3, 60282-2106-4 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| IODINE | 9679TC07X4 | ACTIB |
| GLYCERIN | PDC6A3C0OX | IACT |
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| GLYCERIN | GLYCERIN | PDC6A3C0OX | PASTE / DENTAL | 20 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | ELIXIR / ORAL | 5621 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, EMULSION / INTRAVENOUS | 24100 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION / SUBCUTANEOUS | 450 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | LIQUID / TOPICAL | 2.5 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION/ DROPS / OPHTHALMIC | 12 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | PASTE, DENTIFRICE / DENTAL | 18 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, SOLUTION / INTRAVENOUS | 15 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | PASTE / ORAL | 3822 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | GEL / OPHTHALMIC | 0.88 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION/ DROPS / AURICULAR (OTIC) | 25 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION, CONCENTRATE / ORAL | 200 mg/1ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CAPSULE, EXTENDED RELEASE / ORAL | 265 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CREAM / TOPICAL | 1720 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | DOUCHE / VAGINAL | 1 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION / OPHTHALMIC | 58 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | EMULSION / OPHTHALMIC | 3 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | GUM, CHEWING / BUCCAL | 230 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / RESPIRATORY (INHALATION) | 5 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CAPSULE / ORAL | 3487 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION, EXTENDED RELEASE / ORAL | 2000 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION / AURICULAR (OTIC) | 0.05 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SYSTEM / IONTOPHORESIS | 168.1 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET, COATED / ORAL | 1 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / DENTAL | 15 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / ORAL | 32400 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / OPHTHALMIC | 6 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SPRAY / NASAL | 22.3 mg/1ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUPPOSITORY / RECTAL | 440 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SPONGE / TOPICAL | 2 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | LOTION / TOPICAL | 3990 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION / INTRAVENOUS | 33750 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET, CHEWABLE / ORAL | 12 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUPPOSITORY / VAGINAL | 227.9 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | FILM, EXTENDED RELEASE / TRANSDERMAL | 306.2 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET / PERIODONTAL | 0.53 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CREAM, AUGMENTED / TOPICAL | 55 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION / INTRADERMAL | 1.6 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION / ORAL | 26208 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SYSTEM / TOPICAL | 18144 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / NASAL | 25 mg/1ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | JELLY / VAGINAL | NA | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOAP / TOPICAL | 0.76 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CREAM / VAGINAL | 60 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | LIQUID / ORAL | 2400 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | FILM, EXTENDED RELEASE / BUCCAL | 34 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, SOLUTION / INTRAMUSCULAR | 15 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | OINTMENT / TOPICAL | NA | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | JELLY / TOPICAL | NA | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CONCENTRATE / ORAL | 1800 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CLOTH / TOPICAL | 0.05 mg/mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SHAMPOO / TOPICAL | 5 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SYRUP / ORAL | 16734 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, SUSPENSION / SUBCUTANEOUS | 1.6 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | GEL / TRANSDERMAL | 500 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / TOPICAL | 1971 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | MOUTHWASH / BUCCAL | 100 mg/1ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION / INTRAMUSCULAR | 450 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 225 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION/ DROPS / ORAL | 750 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
